Korean J Obstet Gynecol Search


Korean Journal of Obstetrics & Gynecology 2006;49(12):2612-2619.
Published online December 1, 2006.
A case of treatment of cervical adenocarcinoma associated with pregnancy by zinc-citrate compound (SeLava(R)).
Ji Hyang Choi, Yong Seok Lee, Chan Kwon Jung, Lae Ok Park, Seog Nyeon Bae
1Department of Obstetrics and Gynecology, Kangnam St. Mary's Hospital, The Catholic University of Korea. seognbae@catholic.ac.kr
2Department of Hospital Pathology, Kangnam St. Mary's Hospital, The Catholic University of Korea.
Cervical carcinoma is the second leading cause of death from cancer in women worldwide. It is well known that human papillomaviruses (HPVs) is the etiologic agent of cervical neoplasia and cervical cancer. Zinc has been shown to inhibit the growth of malignant cell lines by inducing apoptosis and cell cycle arrest. Recently it was reported that zinc-citrate compound (CIZAR(R)) has a cytotoxic effect on choriocarcinoma cell line and ovarian adenocarcinoma cell line and suppresses its proliferation inducing apoptosis. CIZAR(R) prevents the proliferation by inactivation of m-aconitase activity and induces apoptosis by increasing Bax expression and reducing Bcl-2 expression and inactivation of telomerase. We report one patient of cervical adenocarcinoma with HPV infection, who desires to continue pregnancy, treated by daily topical application of SeLava(R) which contains zinc-citrate compound (CIZAR(R)). We followed up the cytologic, pathologic and coloposcopic changes of healing process.
Key Words: Cervical adenocarcinoma, Pregnancy, Zinc-citrate compound

Article category

Browse all articles >


Browse all articles >

Editorial Office
4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea.
Tel: +82-2-2266-7238    Fax: +82-2-3445-2440    E-mail: journal@ogscience.org                

Copyright © 2024 by Korean Society of Obstetrics and Gynecology.

Developed in M2PI

Close layer
prev next